Search
Partnering with Genezen
When therapies are as important to patients as cell and gene therapies, it is important to choose the right CMC partner from the start. As Chairman & CEO Steve Favaloro describes, Genezen has been successfully partnering with companies both large and small, and would love to partner with you. Genezen is a best-in-class CDMO with over a decade of experience and state-of-the-art viral vector facilities in Lexington, MA and Indianapolis, IN. If you need help with your AAV, LVV o
Jan 8


This year, our industry has seen many programs held up by CMC issues. As Genezen Chairman & CEO Steve Favaloro describes, having a quality and compliance mindset is key
Genezen is a best-in-class CDMO with over a decade of experience and state-of-the-art viral vector facilities in Lexington, MA and Indianapolis, IN. If you need help with your AAV, LVV or RVV project, please reach out! www.Genezen.com #sponsored
Dec 18, 2025


Scott Hemphill, Site Head of Genezen's Lexington, MA viral vector facility, reflects on the investments and improvements the company has made over the past year
Genezen is a best-in-class CDMO with over a decade of experience and state-of-the-art viral vector facilities. If you need help with your AAV, LVV or RRV project, please reach out! www.Genezen.com #sponsored
Dec 9, 2025


Visiting Genezen Indianpolis to see where it all started - and where the company today makes lenti and retroviral vectors for cell and gene therapies
BiotechTV visited our sponsor Genezen's Indianapolis facility last week where they manufacture lenti and retroviral vectors for gene and...
Aug 13, 2025


BIO International 2025: CEO Steve Favaloro introduces us to Genezen - a best-in-class CDMO with a preclinical to commercial offering
From the floor of the BIO International Convention, he describes the services that Genezen offers, its growth, and how it can partner...
Jun 16, 2025


Welcoming Genezen to the BiotechTV family today as a new sponsor
Genezen is a best-in-class CDMO with over a decade of experience and state-of-the-art viral vector facilities. Genezen's advanced...
Jun 16, 2025


Genezen's CEO discusses the current supply situation in viral vector manufacturing
Steve Favaloro explains why the industry is seeing shortages and what is being done by companies to boost supply.
Oct 19, 2023











.png)

